Atrys Health, S.A. (BME:ATRY)

Market Cap	219.40M
Revenue (ttm)	218.10M
Net Income (ttm)	-31.77M
Shares Out	75.92M
EPS (ttm)	-0.42
PE Ratio	n/a
Forward PE	38.49
Dividend	n/a
Ex-Dividend Date	n/a

Volume	28,201
Average Volume	65,049
Open	2.930
Previous Close	2.890
Day's Range	2.900 - 2.950
52-Week Range	2.480 - 3.790
Beta	0.70
RSI	62.24
Earnings Date	Jul 31, 2025

About Atrys Health

Atrys Health, S.A., together with its subsidiaries, provides diagnostic services and medical treatments in Spain, Portugal, and Latin America. It operates through Diagnosis, Oncology, and Preventive Medicine segments. The company offers integrated diagnostics services comprising structural and molecular pathology, genetics, and nuclear medicine diagnosis; online medical imaging in the fields of radiology and cardiology; oncology treatment services, such as chemotherapy, immunotherapy, radiotherapy, and brachytherapy; second opinion and genetic ...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2007
• Employees: 2,045
• Stock Exchange: Madrid Stock Exchange
• Ticker Symbol: ATRY

Financial Performance

In 2024, Atrys Health's revenue was 218.10 million, an increase of 5.82% compared to the previous year's 206.10 million. Losses were -31.77 million, -30.30% less than in 2023.